D-Wave Quantum (NYSE: QBTS) CEO Highlights Revenue Increase in Fox Business Interview✎ Contributed by Ty Griffin D-Wave reported Q1 2025 revenue of $15 million, up 509% year over...
News
Court Blocks Trump’s EU Tariffs, Wall Street Sees Modest Gains✎ Contributed by Ty Griffin A U.S. federal court has blocked President Donald Trump’s move to impose...
Newton Golf Company (NASDAQ: NWTG) Releases Financial Report, Business Highlights for Q1 2025✎ Contributed by Ty Griffin Newton Golf reports three-figure revenue growth in first quarter of 2025. Newton...
Musk Rebukes Trump’s Economic Plan, EV Stocks Diverge✎ Contributed by Ty Griffin Elon Musk openly criticized President Donald Trump’s proposed “Big Beautiful Bill,” targeting...
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval✎ Contributed by Ty Griffin Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with...
Newton Golf Company (NASDAQ: NWTG) Unveils Fast Motion Shaft for Next-Level Play, Game-Changing Innovation✎ Contributed by Ty Griffin Newton Golf’s new Fast Motion shaft exemplifies how a company can use...
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports 395% Asset Growth in Current Fiscal Year
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports 395% Asset Growth in Current Fiscal Year
SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports 395% Asset Growth in Current Fiscal Year✎ Contributed by Ty Griffin Disseminated on behalf of SolarBank Corporation Total assets rose to $194 million...
Trump’s Tariff Delay Boosts Market Confidence as Indices Climb✎ Contributed by Ty Griffin President Donald Trump has postponed a proposed 50% tariff on European Union...
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 6.9 MW Community Solar Project in Nova ScotiaDisseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will develop the...
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute AcquisitionKadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network of psychiatric...
